178 results on '"Zanetti, Alessandro R."'
Search Results
2. Beyond 30 years of universal anti-hepatitis B vaccination in Italy: Success and areas of improvement
3. Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements
4. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy
5. The worldwide impact of vaccination on the control and protection of viral hepatitis B
6. Genetic and Biological Characterization of Two Hepatitis B Virus Variants: A Precore Mutant Implicated in Fulminant Hepatitis and a Surface Mutant Resistant to Immunoprophylaxis
7. Confirmation of anti-HCV EIA reactivities by RIBA and neutralization assay among blood donors and patients with chronic liver disease and hepatocellular carcinoma
8. Effectiveness of Hepatitis B Vaccination in Babies Born to Hepatitis B Surface Antigen-Positive Mothers in Italy
9. Safety and Immunogenicity of a Conjugate Vaccine against Haemophilus influenzae Type b in Splenectomized and Nonsplenectomized Patients with Cooley Anemia
10. Infectivity and Pathogenicity in Chimpanzees of a Surface Gene Mutant of Hepatitis B Virus That Emerged in a Vaccinated Infant
11. Statements from the Taormina expert meeting on occult hepatitis B virus infection
12. The global impact of vaccination against hepatitis B: A historical overview
13. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents
14. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals
15. Chronic hepatitis B infection in adolescents vaccinated at birth: An alarm bell in favor of the need for a booster?
16. Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements.
17. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply
18. Hepatitis C in Pregnancy and Mother-to-Infant Transmission of HCV
19. Strategies for Global Prevention of Hepatitis B Virus Infection
20. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy infants
21. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women
22. Lack of Effect of a Booster Dose of Influenza Vaccine in Hemodialysis Patients
23. Transfusion of red blood cells from an HIV-RNA-positive/anti-HIV-negative donor without HIV infection in the recipient
24. Modulation of Epitope-Specific Anti-Hepatitis C Virus E2 (Anti-HCV/E2) Antibodies by Anti-Viral Treatment
25. 21 Hepatitis C and pregnancy
26. Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy
27. Primary prevention of hepatitis C virus infection
28. Hepatitis A vaccination in chronic carriers of hepatitis B virus
29. Vaccine-induced escape mutant of hepatitis B virus
30. Confirmation of anti-HCV EIA reactivities by RIBA and neutralization assay among blood donors and patients with chronic liver disease and hepatocellular carcinoma
31. Safety and immunogenicity of influenza vaccination in individuals infected with HIV
32. Immunogenicity and safety of an adjuvanted influenza vaccine in patients with decompensated cirrhosis
33. Update on hepatitis B vaccination in Italy 10 years after its implementation
34. Seroprevalence of HTLV-I and HTLV-II
35. Frequency of respiratory virus infections and next-generation analysis of influenza A/H1N1pdm09 dynamics in the lower respiratory tract of patients admitted to the ICU
36. Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy
37. Seroprevalence of hepatitis E virus among blood donors in northern Italy (Sondrio, Lombardy) determined by three different assays.
38. Hepatitis B vaccination
39. Phylogeography and phylodynamics of European genotype 3 hepatitis E virus
40. Chronic hepatitis B infection in adolescents vaccinated at birth: An alarm bell in favor of the need for a booster?
41. Twenty Years of Universal Vaccination against Hepatitis B in Italy: Achievements and Challenges
42. Switched memory B cells maintain specific memory independently of serum antibodies: The hepatitis B example
43. No Hepatitis After Treatment with a Modified Factor IX Concentrate in Previously Untreated Hemophiliacs
44. Vaccination against hepatitis B and C: the state of the art
45. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma
46. Risk groups for hepatitis A virus infection
47. Total HCV core antigen assay: A new marker of hepatitis C viremia for monitoring the progress of therapy
48. Progress in the prevention and control of viral hepatitis type B: Closing remarks
49. Hepatitis B in Italy: Where we are ten years after the introduction of mass vaccination
50. Safety and Immunogenicity of a Conjugate Vaccine againstHaemophilus influenzaeType b in Splenectomized and Nonsplenectomized Patients with Cooley Anemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.